“…Since the end of the 1930s, the first cases of kidney stones and renal failure related to the use of these products were reported, yet, widely prescribed for their antibiotic properties [7][8][9][10]. Subsequently, the evolution of the pharmacopoeia with the development of more soluble sulfonamides gradually made the clinicians forget the renal risks associated with the crystallization of these products, even if some sporadic publications have described cases of urolithiasis or acute renal failure in patients treated with different sulfonamides antibiotics [11][12][13][14][15][16]. For more than forty years, the presence of numerous drugs, namely foscarnet [17][18][19], atazanavir [20,21], and cisplatin [22,23] have been reported as causative of nephrolithiasis and/or crystalline nephropathy or have been identified in kidneys.…”